We are live on
!
Find out more
MIM
Monashee Investment Management Portfolio holdings
AUM
$184M
1-Year Est. Return
197.43%
This Fund
S&P 500
This Quarter
Est. Return
+101.42%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$669M
AUM Growth
+$482M
(+258%)
Cap. Flow
+$394M
Cap. Flow
% of AUM
58.85%
Top 10 Holdings %
Top 10 Hldgs %
31.65%
Holding
214
New
153
Increased
2
Reduced
1
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NKLA
Nikola Corporation Common Stock
NKLA
|
+$32.1M |
| 2 |
T-Mobile US
TMUS
|
+$29.7M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$22.7M |
| 4 |
DraftKings
DKNG
|
+$17.3M |
| 5 |
PG&E
PCG
|
+$12M |
Top Sells
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.46% |
| 2 | Consumer Discretionary | 19.77% |
| 3 | Communication Services | 8.34% |
| 4 | Technology | 8.26% |
| 5 | Financials | 7.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NKLA
1
DELISTED
Nikola Corporation Common Stock
NKLA
| $67.5M | 10.1% |
+33,333
| New | +$32.1M |
|
|
2
T-Mobile US
TMUS
$193B
| $32.3M | 4.83% |
+310,000
| New | +$29.7M |
|
|
3
Regeneron Pharmaceuticals
REGN
$73.2B
| $24.9M | 3.73% |
+40,000
| New | +$22.7M |
|
|
4
DraftKings
DKNG
$12B
| $20.8M | 3.11% |
+625,000
| New | +$17.3M |
|
5
Aptiv
APTV
$12.5B
| $13.2M | 1.98% |
+170,000
| New | +$11.7M |
|
6
RenaissanceRe
RNR
$13.9B
| $12M | 1.79% |
+70,000
| New | +$11.5M |
|
7
Immatics
IMTX
$1.18B
| $10.8M | 1.61% |
+684,524
| New | +$8.4M |
|
8
American Airlines Group
AAL
$10.1B
| $10.5M | 1.56% |
+800,000
| New | +$9.7M |
|
9
Essent Group
ESNT
$6.28B
| $9.97M | 1.49% |
+275,000
| New | +$8.44M |
|
|
10
PG&E
PCG
$39.2B
| $9.76M | 1.46% |
+1,100,000
| New | +$12M |
|
11
BILL Holdings
BILL
$4.71B
| $9.54M | 1.43% |
+105,718
| New | +$6.81M |
|
12
Royalty Pharma
RPRX
$26.7B
| $8.74M | 1.31% |
+180,000
| New | +$8.91M |
|
13
Guardant Health
GH
$18.8B
| $8.11M | 1.21% |
+100,000
| New | +$8.06M |
|
|
BLUE
14
DELISTED
bluebird bio
BLUE
| $7.93M | 1.19% |
+10,036
| New | +$7.57M |
|
|
CSII
15
DELISTED
Cardiovascular Systems, Inc.
CSII
| $7.89M | 1.18% |
+250,000
| New | +$9.34M |
|
|
FREE
16
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
| $7.59M | 1.13% |
+940,000
| New | +$9.43M |
|
17
JD.com
JD
$43.2B
| $7.52M | 1.12% |
+125,000
| New | +$6.33M |
|
18
Boston Scientific
BSX
$67.3B
| $7.37M | 1.1% |
+210,000
| New | +$7.56M |
|
19
NMI Holdings
NMIH
$3.38B
| $7.08M | 1.06% |
+440,000
| New | +$6.26M |
|
|
LGVW.U
20
DELISTED
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
| $7.07M | 1.06% |
+700,000
| New | +$7.02M |
|
|
MRSN
21
DELISTED
Mersana Therapeutics
MRSN
| $7.02M | 1.05% |
+12,000
| New | +$4.1M |
|
|
ARNA
22
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $6.92M | 1.04% |
+110,000
| New | +$6.05M |
|
23
Invitation Homes
INVH
$17.8B
| $6.88M | 1.03% |
+250,000
| New | +$6.26M |
|
|
FIRY
24
Firy Inc
FIRY
$149M
| $6.59M | 0.98% |
+30,000
| New | +$6.15M |
|
|
AXON
25
Axon Enterprise
AXON
$44.6B
| $6.38M | 0.95% |
+65,000
| New | +$5.26M |
|
Similar funds
EFIC
SWMG
AAM
IFPL
RFG
KWM
NAM
GCGM
Monashee Investment Management's Q2 2020 Portfolio in Review
As of Q2 2020, Monashee Investment Management held 214 positions worth $669M, up 258% from $187M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Monashee Investment Management deployed $394M of net new capital in Q2 2020, opening 153 new positions and adding to 2 existing holdings. Its largest new stake was Nikola Corporation Common Stock: 33,333 shares worth $67.5M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 5.2% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Molecular Templates, Inc., an estimated $1.46M trimmed.
- Monashee Investment Management's largest Q2 2020 buy was Nikola Corporation Common Stock: 33,333 shares worth $67.5M.
- Monashee Investment Management added most to DermTech, Inc. Common Stock in Q2 2020, an estimated $930K increase.
- Monashee Investment Management's biggest Q2 2020 reduction was Molecular Templates, Inc., cutting an estimated $1.46M.
- Monashee Investment Management fully exited State Street SPDR S&P 500 ETF Trust in Q2 2020, selling an estimated $127M.
- Monashee Investment Management's ten largest holdings make up 32% of its $669M portfolio in Q2 2020.
- Monashee Investment Management opened 153 new positions and closed 16 in Q2 2020.
- Monashee Investment Management's portfolio value rose 258% quarter-over-quarter to $669M.
Based on Monashee Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.